Maryland

The Maryland Prescription Drug Affordability Board (PDAB) Stakeholder Council will be held remotely at 2:00 PM on Mon. December 18, 2023, and is open to all stakeholders. The agenda and meeting materials will be available on the Stakeholder Council  page prior to the meeting. After registering, you will receive a confirmation email containing details about joining the meeting. To register for in-person comments, please refer to the Stakeholder Council page. You can find more information about upcoming and previous meetings of the Board and the Council, and presentation materials on the PDAB website.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2023-12-08T10:04:52-05:00December 8, 2023|Maryland|

Massachusetts

The Massachusetts Board of Pharmacy issued the following orders:

  1. Policy 2023-07: Non-Sterile Compounding: Several modifications regarding the addition of flavoring agents were added.
  2. Policy 2023-09: Action Level Environmental Monitoring Results: Clarified that highly pathogenic microorganisms will be those determined by a qualified microbiology professional.
  3. Policy 2020-15: Scope of Practice: Statement that the pharmacist is responsible for the accuracy of the final dispensed prescription was added.
  4. Compounded Ketamine: Edits to this document include the FDA cautions regarding the use of all compounded ketamine products, not just nasal spray.
  5. Sterile Injectable Dispensing (Including Testosterone): Reviews how to interpret the proper days’ supply of injectable vials.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2023-12-08T10:04:23-05:00December 8, 2023|Massachusetts|

Michigan

Medicaid issued a bulletin announcing prescription copay change for Healthy Michigan Plan enrollees.

Also in Michigan, The Department of Licensing and Regulatory Affairs (LARA) issued an email communication to pharmacies regarding the new Pharmacy Technician Administrative Rules that were effective on Oct. 2, 2023. They noted they are diligently working on updating relative information on their website to reflect the revision. Please send questions about the revised rules to BPLHELP@michigan.gov.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2023-12-08T10:03:46-05:00December 8, 2023|Michigan|

Minnesota

The Secretary of State announced open positions on the Prescription Drug Affordability Board (PDAB) and the PDAB Advisory Council. Applications may be submitted on the Open Positions page. If you are interested in applying, please contact NACDS’ Jill McCormack to coordinate.

Also in Minnesota, the Department of Health (MDH) has opened registration to all manufacturers, wholesalers, pharmacies, and pharmacy benefit managers required to submit prescription drug price transparency reports. Beginning in 2024, prescription drug manufacturers, pharmacies, wholesalers, and pharmacy benefit managers will be required to report quarterly on drugs of substantial public interest identified by MDH. All reporting entities are required to register with MDH’s online reporting system beginning January 1, 2024. MDH’s guide to registering provides more detail on the process.

Upcoming Implementation Steps:

  • January 1, 2024: registration requirement goes into effect
  • By January 31, 2024: MDH releases the first list of drugs of substantial public interest for reporting
  • Thirty (30) or more days after the drug list is posted, MDH will notify reporting entities of their reporting obligations; reporting entities have 60 days after the notification is sent to report
  • Early 2024: MDH will release finalized reporting guidance

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2023-12-08T10:02:56-05:00December 8, 2023|Minnesota|

Montana

The Board of Pharmacy and the Board of Veterinary Medicine posted the Joint Full Board Meeting Agenda for December 7. The meeting will be held by teleconference only; see agenda for details. Information is available on the Board meetings page.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2023-12-08T10:01:04-05:00December 8, 2023|Montana|

Nebraska

The Department of Health and Human Services issued Provider Bulletin 23-31: Hepatitis C Virus (HCV) Antiviral Treatment to notify Medicaid providers of upcoming changes to HCV antiviral treatment requirements.

Also in Nebraska, the Department of Health and Human Services issued Provider Bulletin 32-30: Claims for Reinstated Medicaid Members to inform Medicaid providers of members whose coverage has been reinstated due to recent federal guidance. Additional information on Medicaid member reimbursement is also available online, including copays for prescription drugs paid to pharmacies.

Finally in Nebraska, the Department of Health and Human Services posted the draft minutes from the November 14 Drug Utilization Review Board meeting. The next meeting will be held on January 9, 2024.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2023-12-08T10:00:27-05:00December 8, 2023|Nebraska|

Nevada

The next meeting of the Board of Pharmacy will be in Las Vegas on December 6 and 7.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-12-08T09:55:59-05:00December 8, 2023|Nevada|

New York

Effective November 29, the New York Department of Health issued updated guidance regarding dispensing of COVID-19 over-the-counter tests at the pharmacy.

NYRx, the New York State Medicaid Pharmacy Benefit Program, sent a release to pharmacy providers on December 6th. The program continues to field questions and concerns from residency program coordinators about pharmacies not able to submit claims to NYRx written by their interns and residents. NYRx asked the following shared regarding submission of claims:

  1. Provider Manuals (emedny.org)
  2. Provider Manuals – Pharmacy Manual (emedny.org)
  3. pdf (emedny.org)
  4. NYRx, the Medicaid Pharmacy Program | Education & Outreach (fhsc.com)

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2023-12-08T09:55:28-05:00December 8, 2023|New York|

© National Association of Chain Drug Stores
All Rights Reserved | Privacy & Disclaimer

Go to Top